On Tuesday shares of Citigroup Inc. (NYSE:C) closed at $51.94. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 23.24%. Citigroup Inc. (NYSE:C) may have narrowly avoided losing its operating license in Argentina, but bondholders are still between a rock and a hard place after the latest court ruling on Argentina’s debt.
MetLife, Inc. (NYSE:MET) in last trading activity decreased -1.01% to close at $50.89. Company weekly performance is -1.38% while its quarterly performance stands at -4.77%. MetLife, Inc. (NYSE:MET) is -10.10% away from its 52 week high. MetLife Inc. (NYSE:MET) CEO Steven Kandarian is focusing on free cash flow as the key metric for his company after a surge in net income last year failed to boost the stock price. “Nothing is more fundamental than cash,” Kandarian said in a letter Monday to shareholders of the largest U.S. life insurer. “Since the financial crisis, investors have shown increasing skepticism toward reported earnings for life insurers.”
On last trading day Entravision Communications Corporation (NYSE:EVC) decreased -0.44% to close at $6.83. Its volatility for the week is 2.67% while volatility for the month is 3.74%. EVC’s sales growth for past 5 years was 5.00% and its EPS growth for past 5 years was 20.10%. Entravision Communications Corporation (NYSE:EVC) monthly performance is -0.15%. Entravision Communications Corporation (NYSE:EVC) carries a Zacks Rank #2 (Buy).
Mueller Water Products, Inc. (NYSE:MWA) has 0.80% insider ownership while its institutional ownership stands at 88.70%. In last trading activity company’s stock closed at $9.70. Analysts at TheStreet downgraded shares of Mueller Water Products, Inc. (NYSE:MWA) from a “buy” rating to a “hold” rating in a research note.
On last trading day Amarin Corporation plc (NASDAQ:AMRN) advanced 2.86% to close at $2.52. Its volatility for the week is 11.41% while volatility for the month is 11.89%. AMRN’s EPS growth for past 5 years was 15.00%. Amarin Corporation plc (NASDAQ:AMRN) monthly performance is 77.46%.On March 16, 2015 Amarin Corporation plc (ADR) (NASDAQ:AMRN) proclaimed the presentation of findings from a new in vitro study showing that pretreatment with eicosapentaenoic acid (EPA), an omega-3 fatty acid, reduced oxidation of small dense LDL (sdLDL) and resulted in improved endothelial function when compared to other triglyceride (TG)-lowering agents, including fenofibrates, niacin and gemfibrozil.